This application represents the completion of a three year process of consolidation of the University of Wisconsin's two National Cancer Institute Funded Cancer Centers. The McArdle Laboratory for Cancer Research Cancer Center Support Grant will complete 37 years of continuous support in April 2001 and The University of Wisconsin Comprehensive Cancer Center will complete 29 years of continuous support in April 2001. The newly consolidated and greatly expanded University of Wisconsin Comprehensive Cancer Center (UWCCC) is a comprehensive, multi-disciplinary, matrix research institute which supports and stimulates study of the basic biology of cancer, the translation of new discoveries to clinical application, and the study of the incidence and public health related issues of controlling what is the National's number one health problem. The ultimate goal of the faculty and staff of the UWCCC is the prevention and cure of cancer. The UWCCC is ultimate goal of the faculty and staff of the UWCCC is the prevention and cure of cancer The UWCCC is composed of 201 faculty members coming from 41 departments and nine different University schools. The faculty is supported in their work by more than 500 staff. The UWCCC is organized into eight collaborative research programs: Cancer Control and Population Sciences; Cancer Genetics; Cell Signaling and Growth Control; Etiology and Chemoprevention; Experimental Therapeutics; Human Cancer Virology; Imaging and Radiation Sciences; and Immunology and immunotherapy. Four of these programs have clinical trial activity and all eight closely interact with fourteen Disease Oriented Multi-disciplinary Working Groups. The present application proposes to continue support for the CCSGs of the two UW Centers as a newly merged and restructured University based comprehensive cancer center. This application requests renewal of comprehensive status and support for senior leaders, program leaders, staff investigators, planning and evaluation, developmental funds, administration, protocol data review and monitoring, support staff for phase I/II clinical trials, and fifteen shared services essential to facilitate and enhance the multi-disciplinary research of the UWCCC.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA014520-32S1
Application #
6941459
Study Section
Subcommittee G - Education (NCI)
Program Officer
Ciolino, Henry P
Project Start
1976-01-01
Project End
2006-03-31
Budget Start
2004-04-01
Budget End
2005-03-31
Support Year
32
Fiscal Year
2004
Total Cost
$247,043
Indirect Cost
Name
University of Wisconsin Madison
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Liu, Bai; Jones, Monica; Kong, Lin et al. (2018) Evaluation of the biological activities of the IL-15 superagonist complex, ALT-803, following intravenous versus subcutaneous administration in murine models. Cytokine 107:105-112
Yu, Deyang; Yang, Shany E; Miller, Blake R et al. (2018) Short-term methionine deprivation improves metabolic health via sexually dimorphic, mTORC1-independent mechanisms. FASEB J 32:3471-3482
Carroll, Molly J; Fogg, Kaitlin C; Patel, Harin A et al. (2018) Alternatively-Activated Macrophages Upregulate Mesothelial Expression of P-Selectin to Enhance Adhesion of Ovarian Cancer Cells. Cancer Res 78:3560-3573
Ehlerding, Emily B; Grodzinski, Piotr; Cai, Weibo et al. (2018) Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics. ACS Nano 12:2106-2121
Park, Linda; Schwei, R J; Xiong, P et al. (2018) Addressing Cultural Determinants of Health for Latino and Hmong Patients with Limited English Proficiency: Practical Strategies to Reduce Health Disparities. J Racial Ethn Health Disparities 5:536-544
Ehlerding, Emily B; Lan, Xiaoli; Cai, Weibo (2018) ""Albumin Hitchhiking"" with an Evans Blue Analog for Cancer Theranostics. Theranostics 8:812-814
Morris, Zachary S; Guy, Emily I; Werner, Lauryn R et al. (2018) Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites. Cancer Immunol Res 6:825-834
Yu, Bo; Goel, Shreya; Ni, Dalong et al. (2018) Reassembly of 89 Zr-Labeled Cancer Cell Membranes into Multicompartment Membrane-Derived Liposomes for PET-Trackable Tumor-Targeted Theranostics. Adv Mater 30:e1704934
England, Christopher G; Jiang, Dawei; Ehlerding, Emily B et al. (2018) 89Zr-labeled nivolumab for imaging of T-cell infiltration in a humanized murine model of lung cancer. Eur J Nucl Med Mol Imaging 45:110-120
Rutter, Carolyn M; Kim, Jane J; Meester, Reinier G S et al. (2018) Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study. Cancer Epidemiol Biomarkers Prev 27:158-164

Showing the most recent 10 out of 1528 publications